Buscar
aTyr Pharma Ord Shs
LIFEAñadir a la lista de seguimiento
20.420USD
+0.150+0.74%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.29BCap. mercado
PérdidaP/E TTM
Más Datos de aTyr Pharma Ord Shs Compañía
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
Información de aTyr Pharma Ord Shs
Símbolo de cotizaciónLIFE
Nombre de la empresaEthos Technologies Inc
Fecha de salida a bolsaMay 07, 2015
Director ejecutivoColis (Peter George)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 07
Dirección1606 Headway Circle
CiudadAUSTIN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal78754
Teléfono13026365400
Sitio Webhttps://www.ethos.com/
Símbolo de cotizaciónLIFE
Fecha de salida a bolsaMay 07, 2015
Director ejecutivoColis (Peter George)
Ejecutivos de aTyr Pharma Ord Shs
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Mr. Kunal Mehta
Mr. Kunal Mehta
Senior Vice President - Finance
Senior Vice President - Finance
128.16K
-19.88%
Mr. Timothy P. (Tim) Coughlin, CPA
Mr. Timothy P. (Tim) Coughlin, CPA
Independent Chairman of the Board
Independent Chairman of the Board
56.00K
+89.29%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
9.75K
+38.46%
Dr. Svetlana Lucas, Ph.D.
Dr. Svetlana Lucas, Ph.D.
Independent Director
Independent Director
6.00K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter Colis
Mr. Peter Colis
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
Co-Founder, Chairman of the Board of Director, Chief Executive Officer
900.00K
--
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, Director, President
Co-Founder, Director, President
900.00K
--
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
264.46K
-97.02%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
Dr. Sanjay S. Shukla, M.D.
Dr. Sanjay S. Shukla, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
153.55K
+4.32%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de aTyr Pharma Ord Shs?
Los cinco principales accionistas de aTyr Pharma Ord Shs son: Mr. Peter Colis
¿Cuántas instituciones poseen acciones de aTyr Pharma Ord Shs (LIFE)?
A fecha de 2026Q1, 258 instituciones poseen acciones de aTyr Pharma Ord Shs, con un valor de mercado combinado de aproximadamente 61.21M, lo que representa el 88.45% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -10216639.00.